Fifth Third Wealth Advisors LLC Has $770,000 Holdings in HCA Healthcare, Inc. $HCA

Fifth Third Wealth Advisors LLC boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 25.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,009 shares of the company’s stock after buying an additional 402 shares during the quarter. Fifth Third Wealth Advisors LLC’s holdings in HCA Healthcare were worth $770,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the business. Price T Rowe Associates Inc. MD grew its position in shares of HCA Healthcare by 83.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after purchasing an additional 1,091,416 shares during the last quarter. Goldman Sachs Group Inc. grew its position in shares of HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock valued at $615,583,000 after purchasing an additional 587,036 shares during the last quarter. Nuveen LLC acquired a new position in shares of HCA Healthcare in the first quarter valued at approximately $569,217,000. Pacer Advisors Inc. grew its position in shares of HCA Healthcare by 6,237.9% in the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock valued at $466,815,000 after purchasing an additional 1,329,618 shares during the last quarter. Finally, Principal Financial Group Inc. grew its position in shares of HCA Healthcare by 0.8% in the first quarter. Principal Financial Group Inc. now owns 880,663 shares of the company’s stock valued at $304,313,000 after purchasing an additional 6,888 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity

In other news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This represents a 10.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.30% of the stock is owned by company insiders.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $414.73 on Monday. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $439.01. The company has a market cap of $97.04 billion, a PE ratio of 17.43, a P/E/G ratio of 1.31 and a beta of 1.40. The stock’s fifty day moving average price is $405.12 and its two-hundred day moving average price is $376.08.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same period in the prior year, the business posted $5.50 earnings per share. HCA Healthcare’s quarterly revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio is 12.11%.

Wall Street Analysts Forecast Growth

HCA has been the subject of several recent research reports. Barclays boosted their price target on HCA Healthcare from $390.00 to $445.00 and gave the company an “overweight” rating in a research note on Thursday, September 18th. KeyCorp boosted their price target on HCA Healthcare from $370.00 to $465.00 and gave the company an “overweight” rating in a research note on Wednesday. Bank of America boosted their price target on HCA Healthcare from $375.00 to $410.00 and gave the company a “neutral” rating in a research note on Wednesday, September 10th. Robert W. Baird boosted their price target on HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research note on Thursday, August 14th. Finally, Weiss Ratings reiterated a “buy (b-)” rating on shares of HCA Healthcare in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $422.31.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.